Christoph Königs
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Dynamics of the Anti-factor VIII Antibody Signature During Treatment With Emicizumab (NCT05802836) | Christoph Königs | 2023-04-26 |
Track Christoph Königs automatically
Every clearance here is in the API, with alerts when new ones post.